Healthcare, pharma, and biotech innovation

Healthcare
pharma,
and biotech
innovation

Oliba helps healthcare, pharma, and biotech organizations bridge the gap between patients, caregivers, and healthcare professionals and sustainable innovation, safeguarding wellness, and increasing empowerment for making appropriate healthcare and business decisions.

The Oliba team researches and develops comprehensive overviews of the clinical, regulatory, organizational, and financial impact of the introduction of advanced therapies, even before marketing authorization.

The team devises strategic programs to market innovative therapeutic and diagnostic technologies, including commercial strategy design and implementation, sales forecasting, institutional relationships with local and national authorities, and communication and education campaigns.

Oliba is a boutique consulting company that specializes in healthcare, pharmaceutical and biotech scientific innovation. We understand the importance of developing and coordinating scientific projects and partnerships. Our team of experienced professionals has the knowledge and expertise to support clients in developing scientific projects from conception through implementation to completion.

The Oliba team works closely with clients to identify the most promising research ideas and technologies, and to develop comprehensive plans for putting these ideas into action. We help clients to identify potential partners, funding sources, and legal and regulatory aspects of partnerships to ensure that all parties are aligned with the goals and objectives of the project, thus driving project success.

Oliba has a proven track record of success in developing and coordinating scientific projects and partnerships in the healthcare, pharmaceutical and biotech sectors, collaborating with academic institutions, pharmaceutical companies, and government agencies.

Development and coordination of healthcare projects and partnerships

Project case

The NCD partnership / Viatris

The NCD partnership focused on the common goal of improving the lives of patients with non-communicable diseases during the pandemic, implementing various activities and skills on three interconnected projects:

Expert opinion paper highlighting pandemic risks, restrictions and other health interventions targeting patients with non-communicable diseases. At the start of the pandemic, the partnership published one of the first expert opinion-based studies and an evidence-based prospective article that emphasized the unmet needs of patients with NCDs during the crisis and the potential risks of short-term control measures and long-term in patient management.
Virtual advisory board between associations of patients with non-communicable diseases and public and private stakeholders. The partnership also organized an advisory board on the challenges and needs of patients with noncommunicable diseases during and after the pandemic. The perspectives collected were published in a peer-reviewed journal. This event was implemented to ensure that policy makers, healthcare professionals, researchers and industry experts worked together, also taking into account the direct voice and opinions of patients and healthcare professionals.
Advisory board with caregivers aimed at empowering patients. A second advisory board with caregivers and healthcare specialists focused specifically on the unmet needs of patients during the pandemic. This event was patient-led, with attendees identifying the need to implement new digital tools to support disease management during the pandemic as a priority topic. The views collected were integrated and published in a peer-reviewed journal.